NM_001909.5:c.828-17G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001909.5(CTSD):​c.828-17G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.069 in 1,604,836 control chromosomes in the GnomAD database, including 4,220 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.055 ( 272 hom., cov: 33)
Exomes 𝑓: 0.070 ( 3948 hom. )

Consequence

CTSD
NM_001909.5 intron

Scores

1
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -3.09

Publications

7 publications found
Variant links:
Genes affected
CTSD (HGNC:2529): (cathepsin D) This gene encodes a member of the A1 family of peptidases. The encoded preproprotein is proteolytically processed to generate multiple protein products. These products include the cathepsin D light and heavy chains, which heterodimerize to form the mature enzyme. This enzyme exhibits pepsin-like activity and plays a role in protein turnover and in the proteolytic activation of hormones and growth factors. Mutations in this gene play a causal role in neuronal ceroid lipofuscinosis-10 and may be involved in the pathogenesis of several other diseases, including breast cancer and possibly Alzheimer's disease. [provided by RefSeq, Nov 2015]
CTSD Gene-Disease associations (from GenCC):
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis 10
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0028076768).
BP6
Variant 11-1754155-C-T is Benign according to our data. Variant chr11-1754155-C-T is described in ClinVar as Benign. ClinVar VariationId is 258490.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0814 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CTSDNM_001909.5 linkc.828-17G>A intron_variant Intron 6 of 8 ENST00000236671.7 NP_001900.1 P07339V9HWI3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CTSDENST00000236671.7 linkc.828-17G>A intron_variant Intron 6 of 8 1 NM_001909.5 ENSP00000236671.2 P07339
ENSG00000250644ENST00000636615.1 linkc.828-17G>A intron_variant Intron 6 of 9 5 ENSP00000490014.1 A0A1B0GU92

Frequencies

GnomAD3 genomes
AF:
0.0550
AC:
8372
AN:
152104
Hom.:
271
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0246
Gnomad AMI
AF:
0.0241
Gnomad AMR
AF:
0.0614
Gnomad ASJ
AF:
0.0902
Gnomad EAS
AF:
0.0291
Gnomad SAS
AF:
0.0886
Gnomad FIN
AF:
0.0422
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.0716
Gnomad OTH
AF:
0.0708
GnomAD2 exomes
AF:
0.0636
AC:
14967
AN:
235162
AF XY:
0.0674
show subpopulations
Gnomad AFR exome
AF:
0.0240
Gnomad AMR exome
AF:
0.0422
Gnomad ASJ exome
AF:
0.0957
Gnomad EAS exome
AF:
0.0340
Gnomad FIN exome
AF:
0.0462
Gnomad NFE exome
AF:
0.0714
Gnomad OTH exome
AF:
0.0788
GnomAD4 exome
AF:
0.0705
AC:
102338
AN:
1452614
Hom.:
3948
Cov.:
37
AF XY:
0.0714
AC XY:
51633
AN XY:
722702
show subpopulations
African (AFR)
AF:
0.0233
AC:
779
AN:
33404
American (AMR)
AF:
0.0436
AC:
1938
AN:
44492
Ashkenazi Jewish (ASJ)
AF:
0.0890
AC:
2319
AN:
26060
East Asian (EAS)
AF:
0.0257
AC:
1015
AN:
39560
South Asian (SAS)
AF:
0.0936
AC:
8028
AN:
85810
European-Finnish (FIN)
AF:
0.0464
AC:
2171
AN:
46826
Middle Eastern (MID)
AF:
0.112
AC:
640
AN:
5724
European-Non Finnish (NFE)
AF:
0.0730
AC:
81062
AN:
1110610
Other (OTH)
AF:
0.0729
AC:
4386
AN:
60128
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
5129
10258
15388
20517
25646
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3018
6036
9054
12072
15090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0550
AC:
8367
AN:
152222
Hom.:
272
Cov.:
33
AF XY:
0.0539
AC XY:
4007
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.0245
AC:
1019
AN:
41564
American (AMR)
AF:
0.0613
AC:
938
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0902
AC:
313
AN:
3470
East Asian (EAS)
AF:
0.0288
AC:
148
AN:
5142
South Asian (SAS)
AF:
0.0883
AC:
426
AN:
4826
European-Finnish (FIN)
AF:
0.0422
AC:
448
AN:
10622
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.0716
AC:
4870
AN:
67976
Other (OTH)
AF:
0.0720
AC:
152
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
392
784
1176
1568
1960
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0708
Hom.:
131
Bravo
AF:
0.0540
TwinsUK
AF:
0.0693
AC:
257
ALSPAC
AF:
0.0729
AC:
281
ESP6500AA
AF:
0.0248
AC:
109
ESP6500EA
AF:
0.0693
AC:
596
ExAC
AF:
0.0614
AC:
7416
Asia WGS
AF:
0.0790
AC:
272
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 15, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Neuronal ceroid lipofuscinosis 10 Benign:2
Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 21, 2016
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Neuronal ceroid lipofuscinosis Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
0.017
DANN
Benign
0.87
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.021
N
LIST_S2
Benign
0.23
T
MetaRNN
Benign
0.0028
T
MetaSVM
Benign
-1.1
T
PhyloP100
-3.1
PROVEAN
Benign
0.0
N
REVEL
Benign
0.13
Sift
Uncertain
0.0050
D
Sift4G
Benign
0.19
T
ClinPred
0.0022
T
GERP RS
-5.6
PromoterAI
-0.011
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78735768; hg19: chr11-1775385; COSMIC: COSV52589176; COSMIC: COSV52589176; API